Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy
- 10 September 2002
- journal article
- Published by Elsevier
- Vol. 40 (5) , 961-966
- https://doi.org/10.1016/s0735-1097(02)02061-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibitionJournal of the American College of Cardiology, 2001
- Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitorsJournal of the American College of Cardiology, 2001
- Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular ReactivityHypertension, 2001
- Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B 2 Receptor–Dependent, NO Synthase–Independent, and Cyclooxygenase-Independent PathwayCirculation, 2000
- Predictors of congestive heart failure in the elderly: the cardiovascular health studyJournal of the American College of Cardiology, 2000
- The role of tumor necrosis factor in the pathophysiology of heart failureJournal of the American College of Cardiology, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- The l-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in manCardiovascular Research, 1998
- Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.The Journal of Physiology, 1989
- Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasmaBlood, 1988